Inflammatory response assessment of a hybrid tissue-engineered heart valve leaflet

Annals of Biomedical Engineering

Volumn 41, Issue 2, 2013, Pages 316-326

  Alavi, S Hamed ^a   Liu, Wendy F ^a   Kheradvar, Arash ^a  

^a University of California at Irvine   (United States)

Author keywords

Hybrid heart valve; Inflammatory response; Metal mesh scaffold; THP 1 cell line

Indexed keywords

BIOCOMPATIBILITY; CELL CULTURE; DYNAMIC LOADS; HEART; MESH GENERATION; METALS; SCAFFOLDS; TISSUE;

BIOLOGICAL SCAFFOLDS; EXTRACELLULAR MATRICES; HEART VALVES; INFLAMMATORY RESPONSE; METAL MESH; THP-1 CELLS; TISSUE-ENGINEERED HEART; TISSUE-ENGINEERED SCAFFOLDS;

SCAFFOLDS (BIOLOGY);

ALLOY; BIOMATERIAL; COLLAGEN TYPE 1; NITINOL; STAINLESS STEEL; TISSUE SCAFFOLD; TUMOR NECROSIS FACTOR ALPHA;

AORTA; ARTICLE; CELL LINE; CYTOLOGY; ENDOTHELIUM CELL; FIBROBLAST; HEART VALVE; HUMAN; IMMUNOLOGY; INFLAMMATION; MACROPHAGE; SMOOTH MUSCLE FIBER; TISSUE ENGINEERING; UMBILICAL CORD;

ALLOYS; AORTA; BIOCOMPATIBLE MATERIALS; CELL LINE; COLLAGEN TYPE I; ENDOTHELIAL CELLS; FIBROBLASTS; HEART VALVES; HUMANS; INFLAMMATION; MACROPHAGES; MYOCYTES, SMOOTH MUSCLE; STAINLESS STEEL; TISSUE ENGINEERING; TISSUE SCAFFOLDS; TUMOR NECROSIS FACTOR-ALPHA; UMBILICAL CORD;

MLCS; MLOWN;

EID: 84878497503     PISSN: 00906964     EISSN: 15739686     Source Type: Journal    
DOI: 10.1007/s10439-012-0664-7     Document Type: Article

References (41)

1. Alavi, S. H.; and A. Kheradvar. Metal mesh scaffold for tissue engineering of membranes. Tissue Eng. Part C Methods 18:293-301, 2011.
2. Anderson, J. M. Inflammatory response to implants. ASAIO J. 34:101, 1988.
3. Anderson, J. M.; A. Rodriguez, and D. T. Chang. Foreign body reaction to biomaterials. Semin. Immunol. 20:86-100, 2008.
4. Apte, S. S.; A. Paul, S. Prakash, and D. Shum-Tim. Current developments in the tissue engineering of autologous heart valves: moving towards clinical use. Futur. Cardiol. 7:77-97, 2011.
5. Auwerx, J. The human leukemia cell line, THP-1: a multifacetted model for the study of monocyte-macrophage differentiation. Cell. Mol. Life Sci. 47:22-31, 1991.
6. Boontheekul, T.; and D. J. Mooney. Protein-based signaling systems in tissue engineering. Curr. Opin. Biotechnol. 14:559-565, 2003.
7. Breuer, C. K.; B. A. Mettler, T. Anthony, V. L. Sales, F. J. Schoen, and J. E. Mayer. Application of tissue-engineering principles toward the development of a semilunar heart valve substitute. Tissue Eng. 10:1725-1736, 2004.
8. Butcher, J. T.; and R. M. Nerem. Porcine aortic valve interstitial cells in three-dimensional culture: comparison of phenotype with aortic smooth muscle cells. J. Heart Valve Dis. 13:478-486, 2004.
9. Butcher, J. T.; A. M. Penrod, A. J. García, and R. M. Nerem. Unique morphology and focal adhesion development of valvular endothelial cells in static and fluid flow environments. Arterioscler. Thromb. Vasc. Biol. 24:1429-1434, 2004.
10. Chester, A. H.; and P. M. Taylor. Molecular and functional characteristics of heart-valve interstitial cells. Philos. Trans. R. Soc. B: Biol. Sci. 362:1437-1443, 2007.
11. Filip, D.; A. Radu, and M. Simionescu. Interstitial cells of the heart valves possess characteristics similar to smooth muscle cells. Circ. Res. 59:310-320, 1986.
12. Flanagan, T. C.; and A. Pandit. Living artificial heart valve alternatives: a review. Eur. Cell Mater. 6:28-45, 2003.
13. Frankenberger, M.; A. Pforte, T. Sternsdorf, B. Passlick, P. Baeuerle, and H. Ziegler-Heitbrock. Constitutive nuclear NF-kappa B in cells of the monocyte lineage. Biochem. J. 304:87, 1994.
14. Grande-Allen, K.; and J. Liao. The heterogeneous biomechanics and mechanobiology of the mitral valve: implications for tissue engineering. Curr. Cardiol. Rep. 13:113-120.
15. Hammermeister, K. E.; G. K. Sethi, W. G. Henderson, C. Oprian, T. Kim, and S. Rahimtoola. A comparison of outcomes in men 11 years after heart-valve replacement with a mechanical valve or bioprosthesis. N. Engl. J. Med. 328:1289-1296, 1993.
16. Heil, T.; K. Volkmann, J. Wataha, and P. Lockwood. Human peripheral blood monocytes versus THP-1 monocytes for in vitro biocompatibility testing of dental material components. J. Oral Rehabil. 29:401-407, 2002.
17. Hoerstrup, S. P.; R. Sodian, S. Daebritz, J. Wang, E. A. Bacha, D. P. Martin, A. M. Moran, K. J. Guleserian, J. S. Sperling, S. Kaushal, J. P. Vacanti, F. J. Schoen, and J. E. Mayer, Jr. Functional living trileaflet heart valves grown in vitro. Circulation 102(III):44-49, 2000.
18. Klinger, A.; D. Steinberg, D. Kohavi, and M. Sela. Mechanism of adsorption of human albumin to titanium in vitro. J. Biomed. Mater. Res. 36:387-392, 1997.
19. Lee, S.; F. Brennan, J. Jacobs, R. Urban, D. Ragasa, and T. Glant. Human monocyte/macrophage response to cobalt-chromium corrosion products and titanium particles in patients with total joint replacements. J. Orthop. Res. 15:40-49, 1997.
20. Liu, W. F.; M. Ma, K. M. Bratlie, T. T. Dang, R. Langer, and D. G. Anderson. Real-time in vivo detection of biomaterial-induced reactive oxygen species. Biomaterials 32:1796-1801, 2011.
21. Lynn, A.; I. Yannas, and W. Bonfield. Antigenicity and immunogenicity of collagen. J. Biomed. Mater. Res. B Appl. Biomater. 71:343-354, 2004.
22. Ma, M.; W. F. Liu, P. S. Hill, K. M. Bratlie, D. J. Siegwart, J. Chin, M. Park, J. Guerreiro, and D. G. Anderson. Development of cationic polymer coatings to regulate foreign-body responses. Adv. Mater. 2011.
23. Mendelson, K.; and F. Schoen. Heart valve tissue engineering: concepts, approaches, progress, and challenges. Ann. Biomed. Eng. 34:1799-1819, 2006.
24. Rabkin, E.; and F. J. Schoen. Cardiovascular tissue engineering. Cardiovasc. Pathol. 11:305-317, 2002.
25. Rabkin-Aikawa, E.; J. E. Mayer, Jr.; and F. J. Schoen. Heart valve regeneration. Adv. Biochem. Eng. Biotechnol. 94:141-179, 2005.
26. Ryhänen, J. Biocompatibility evaluation of nickel-titanium shape memory metal alloy. Oulun yliopisto, 1999.
27. Sacks, M. S.; F. J. Schoen, and J. E. Mayer. Bioengineering challenges for heart valve tissue engineering. Annu. Rev. Biomed. Eng. 11:289-313, 2009.
28. Schoen, F. J.; and R. J. Levy. Tissue heart valves: current challenges and future research perspectives. J. Biomed. Mater. Res. 47:439-465, 1999.
29. Shah, S. R.; and N. R. Vyavahare. The effect of glycosaminoglycan stabilization on tissue buckling in bioprosthetic heart valves. Biomaterials 29:1645-1653, 2008.
30. Shinoka, T.; C. K. Breuer, R. E. Tanel, G. Zund, T. Miura, P. X. Ma, R. Langer, J. P. Vacanti, and J. E. Mayer, Jr. Tissue engineering heart valves: valve leaflet replacement study in a lamb model. Ann. Thorac. Surg. 60:S513-S516, 1995.
31. Shinoka, T.; P. X. Ma, D. Shum-Tim, C. K. Breuer, R. A. Cusick, G. Zund, R. Langer, J. P. Vacanti, and J. E. Mayer, Jr. Tissue-engineered heart valves. Autologous valve leaflet replacement study in a lamb model. Circulation 94:164-168, 1996.
32. Steinhoff, G.; U. Stock, N. Karim, H. Mertsching, A. Timke, R. R. Meliss, K. Pethig, A. Haverich, and A. Bader. Tissue engineering of pulmonary heart valves on allogenic acellular matrix conduits: in vivo restoration of valve tissue. Circulation 102(III):50-55, 2000.
33. Stephens, E. H.; N. de Jonge, M. P. McNeill, C. A. Durst, and K. J. Grande-Allen. Age-related changes in material behavior of porcine mitral and aortic valves and correlation to matrix composition. Tissue Eng. Part A 16:867-878, 2009.
34. Syedain, Z. H.; and R. T. Tranquillo. Controlled cyclic stretch bioreactor for tissue-engineered heart valves. Biomaterials 30:4078-4084, 2009.
35. Thierry, B.; M. Tabrizian, C. Trepanier, O. Savadogo, and L. H. Yahia. Effect of surface treatment and sterilization processes on the corrosion behavior of NiTi shape memory alloy. J. Biomed. Mater. Res. 51:685-693, 2000.
36. Tsuchiya, S.; Y. Kobayashi, Y. Goto, H. Okumura, S. Nakae, T. Konno, and K. Tada. Induction of maturation in cultured human monocytic leukemia cells by a phorbol diester. Cancer Res. 42:1530, 1982.
37. van Geemen, D.; P. Riem Vis, S. Soekhradj-Soechit, J. Sluijter, M. de Liefde-van Beest, J. Kluin, and C. Bouten. Decreased mechanical properties of heart valve tissue constructs cultured in platelet lysate as compared to fetal bovine serum. Tissue Eng. Part C Methods 7:607-617, 2011.
38. Vesely, I. Heart valve tissue engineering. Circ. Res. 97:743-755, 2005.
39. Vince, D. G.; J. A. Hunt, and D. F. Williams. Quantitative assessment of the tissue response to implanted biomaterials. Biomaterials 12:731-736, 1991.
40. Wataha, J.; P. Lockwood, M. Marek, and M. Ghazi. Ability of Ni-containing biomedical alloys to activate monocytes and endothelial cells in vitro. J. Biomed. Mater. Res. 45:251-257, 1999.
41. Wataha, J. C.; S. Ratanasathien, C. T. Hanks, and Z. Sun. In vitro IL-1 [beta] and TNF-[alpha] release from THP-1 monocytes in response to metal ions. Dent. Mater. 12:322-327, 1996.